Jul 21, 2026

H.R. 3029: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes. — Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

H.R. 3029: Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes. — Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

Type: bill-action | Source: congress.gov


{
  "platform": "civiq",
  "version": 1,
  "type": "bill-action",
  "data": {
    "billId": "hr3029-119",
    "billType": "hr",
    "billNumber": "3029",
    "congress": 119,
    "actionText": "Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.",
    "actionDate": "2026-07-21",
    "chamber": "House"
  },
  "source": {
    "url": "https://api.congress.gov/v3/bill/119/hr/3029?format=json",
    "api": "congress.gov"
  }
}